Herpes gestationis in a mother and newborn: Immunoclinical perspectives based on a weekly follow-up of the enzyme-linked immunosorbent assay index of a bullous pemphigoid antigen noncollagenous domain

Archives of Dermatology

Volumn 143, Issue 9, 2007, Pages 1168-1172

  Aoyama, Yumi ^a   Asai, Kanako ^a   Hioki, Kana ^a   Funato, Michinori ^a   Kondo, Naomi ^a   Kitajima, Yasuo ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BULLOUS PEMPHIGOID 180 ANTIBODY; BULLOUS PEMPHIGOID ANTIGEN 1; PEMPHIGUS ANTIBODY; PREDNISOLONE; UNCLASSIFIED DRUG;

ADULT; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; CLINICAL FEATURE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MALE; NEWBORN; PEMPHIGOID GESTATIONIS; PRIORITY JOURNAL; PUERPERIUM; RARE DISEASE; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; TREATMENT PLANNING;

ADULT; AUTOANTIBODIES; AUTOANTIGENS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFANT, NEWBORN; NON-FIBRILLAR COLLAGENS; PEMPHIGOID GESTATIONIS; PREGNANCY;

EID: 34548820998     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.143.9.1168     Document Type: Article

References (14)

1. Jenkins RE, Hern S, Black MM. Clinical features and management of 87 patients with pemphigoid gestationis. Clin Exp Dermatol. 1999;24(4):255-259.
2. Shornick JK, Bangert JL, Freeman RG, Gilliam JN. Herpes gestationis: clinical and histologic features of twenty-eight cases. J Am Acad Dermatol. 1983;8(2):214-224.
3. Lin MS, Arteaga LA, Diaz LA. Herpes gestationis. Clin Dermatol. 2001;19(6):697-702.
4. Provost TT, Tomasi TB Jr. Evidence for complement activation via the alternate pathway in skin diseases, I: herpes gestationis, systemic lupus erythematosus, and bullous pemphigoid. J Clin Invest. 1973;52(7):1779-1787.
5. Bushkell LL, Jordon RE, Goltz RW. Herpes gestationis: new immunologic findings. Arch Dermatol. 1974;110(1):65-69.
6. Giudice GJ, Wilske KC, Anhalt GJ, et al. Development of an ELISA to detect anti-BP180 autoantibodies in bullous pemphigoid and herpes gestationis. J Invest Dermatol. 1994;102(6):878-881.
7. Matsumura K, Amagai M, Nishikawa T, Hashimoto T. The majority of bullous pemphigoid and herpes gestationis serum samples react with the NC16a domain of the 180-kDa bullous pemphigoid antigen. Arch Dermatol Res. 1996;288(9):507-509.
8. Lin MS, Gharia M, Fu CL, et al. Molecular mapping of the major epitopes of BP180 recognized by herpes gestationis autoantibodies. Clin Immunol. 1999;92(3):285-292.
9. Sitaru C, Powell J, Messer G, Brocker EB, Wojnarowska F, Zillikens D. Immunoblotting and enzyme-linked immunosorbent assay for the diagnosis of pemphigoid gestationis. Obstet Gynecol. 2004;103(4):757-763.
10. Shornick JK, Stastny P, Gilliam JN. High frequency of histocompatibility antigens HLA-DR3 and DR4 in herpes gestations. J Clin Invest. 1981;68(2):553-555.
11. Chorzelski TP, Jablonska S, Beutner EH, Maciejowska E, Jarzabek-Chorzelska M. Herpes gestations with identical lesions in the newborn: passive transfer of the disease? Arch Dermatol. 1976;112(8):1129-1131.
12. Katz A, Minto JO, Toole JW, Medwidsky W. Immunopathologic study of herpes gestationis in mother and infant. Arch Dermatol. 1977;113(8):1069-1072.
13. Kitajima Y, Nojiri M, Yamada T, Hirako Y, Owaribe K. InternalizationkDa bullous pemphigoid antigen as immune complexes in basal keratinocytes: of the 180 an important early event in blister formation in bullous pemphigoid. Br J Dermatol. 1998;138(1):71-76.
14. Baxi LV, Kovilam OP, Collins MH, Walther RR. Recurrent herpes gestationis with postpartum flare: a case report. Am J Obstet Gynecol. 1991;164(3):778-780.